Andrew Prigge, MD

Clinical and Community Trials
Pronoun: He, Him, His

“My research is focused on understanding how children recover from severe viral pneumonia. My goal is to develop therapies that will accelerate recovery, thereby minimizing the effects of critical illness and helping children return home more quickly.”

Research Interests

  • Critical Care
  • Viral Respiratory Infections
  • Lung Injury and Repair
  • Immune Regulation


  • Attending Physician, Critical Care, Ann & Robert H. Lurie Children’s Hospital of Chicago 
  • Instructor of Pediatrics (Critical Care), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Andrew Prigge, MD, is a physician-scientist who specializes in Pediatric Critical Care Medicine. He is an Instructor of Pediatrics at Northwestern University Feinberg School of Medicine and a Post-Doctoral Scholar in the Northwestern University T32 Training Program in Lung Science. Dr. Prigge’s research is focused on determinants of recovery from severe viral pneumonia in children. His research program integrates highly dimensional data from human samples with mechanistically driven laboratory experiments to understand how the pediatric immune system mediates resolution of inflammation and repair of lung tissue. His work seeks to inform the design of new therapeutics to hasten the recovery of critically ill children with viral respiratory infections. 

Education and Background

  • Fellowship, Ann & Robert H. Lurie Children’s Hospital of Chicago 2018-2021
  • Chief Resident, UPMC Children’s Hospital of Pittsburgh 2018
  • Residency, UPMC Children’s Hospital of Pittsburgh 2014-2017
  • MD, University Of Rochester School Of Medicine And Dentistry 2014
  • BS, University of Wisconsin-Madison 2010

Featured Grants

Northwestern University Lung Sciences Training Program

National Institutes of Health/National Heart, Lung, and Blood Institute
07/01/2021 → 06/30/2023

Similar Researchers

Clinical and Community Trials

Research Interests

Interventricular Mechanics, Right Ventricular Failure, Role of Immunologic Phenotype on Post-heart Transplant Outcomes, Post-heart Transplant Kidney Injury and Failure

Clinical and Community Trials